Dose-Adjusted Epoch R in Hodgkin's Lymphoma?

I think that the data continues to state that it appears to be somewhat agnostic to subtype of interest, and I don't think that we all have the 99% of IAC. You know, so I think gene expression profiling by IHC is probably going out the window as well as IHC. Some people are doing it in order to dichotomize more for those who you should do fish on with C-mic expression plus Dose adjusted epoch R.